Learn more

BIOMARK TECHNOLOGIES INC

Overview
  • Total Patents
    23
  • GoodIP Patent Rank
    168,118
About

BIOMARK TECHNOLOGIES INC has a total of 23 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CANCERFORSKNINGSFONDET AF 1989, CANCERFORSKNINGSFONDEN AF 1989 and INDI MOLECULAR INC.

Patent filings in countries

World map showing BIOMARK TECHNOLOGIES INCs patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 7
#2 Canada 5
#3 China 5
#4 EPO (European Patent Office) 3
#5 United States 3

Patent filings per year

Chart showing BIOMARK TECHNOLOGIES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cheng Brian 23
#2 Bux Rashid 22
#3 Cheng Derek 10
#4 Ramjiawan Bram 9
#5 Sitar Daniel 6
#6 Aversa Gregorio 5
#7 Gordon Reuven 3
#8 Ahmed Aftab 3
#9 Hof Fraser Alan 3
#10 Sitar Daniel S 2

Latest patents

Publication Filing date Title
WO2015188273A1 Method of detecting cancer based on spermine/spermidine n'-acetyltransferase gene expression
WO2015027345A1 An immunological assay to detect and quantify acetylamantadine
CN105209910A Detection and quantification of acetylamantadine in urine samples
US2016017054A1 Spermidine/Spermine N1 - Acetyltransferase Antibodies As Anti-Cancer Drug Compounds
WO2014075187A1 Spermidine/spermine n1-acetyltransferase substrates as anti-cancer drug compounds
CN103975074A A method for assaying the activity of spermidine/spermine n1-acetyltrasferase
WO2012151702A1 Monoclonal antibody for acetylamantadine